Sarissa Capital Management LP Abb Vie Inc. Transaction History

Sarissa Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $26.6 Million - $31.3 Million	-310,150 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $22.7 Million - $30.4 Million	309,150 Added 30915.0%	310,150 $30.5 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $828,090 - $1.11 Million	-9,000 Reduced 90.0%	1,000 $94,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $698,500 - $892,200	10,000	10,000 $888,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Sarissa Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Sarissa Capital Management LP with notifications on news.